Drug Database
Back to search

Belgium· BE-AMP-SAM096153-00

Questran 4 g

A colestyramine product containing colestyramine, registered in Belgium by Cheplapharm Arzneimittel. The same ATC class is registered in 13 of our 19 countries.

ATC C10AC01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedQuestran 4 gATCC10AC01REGISTER NO.BE-AMP-SAM096153-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about colestyramineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Colestyramine is registered in 13 of 19 countries.

Countries holding a registration under ATC C10AC01 (colestyramine), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose
Search colestyramine products by name

Colestyramine · ATC C10AC01

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Colestyramine
Manufacturer
Cheplapharm Arzneimittel
Country
Belgium (BE)
ATC code
C10AC01
ATC class
Colestyramine
Defined daily dose
14 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

1 priced
  • be_apb
    0073296
    EUR 26.56
  • be_apb
    0716159

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

88 interactions on record for colestyramine.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check colestyramine against other medicinesHow interaction checks work

Colestyramine · interactions on record

88 records

  • 3 severe
  • 73 moderate
  • 7 minor

Most severe, free to view

  • Mycophenolic acidL04AA06severe
  • TeriflunomidL04AA31severe
  • TeriflunomideL04AK02severe
  • Chenodeoxycholic acidA05AA01moderate

5 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Colestyramine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All colestyramine products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Austria · Quantalan Zuckerfrei
  • Cyprus · Resincolestiramina
  • Germany · Colestyramin 1 A Pharma, Colestyramin Ratiopharm
  • Denmark · Colestyramin Orifarm
  • Spain · Efensol, Resincolestiramina
  • Finland · Questran
  • France · Questran
  • United Kingdom (Northern Ireland) · Colestyramine Light Laboratorios Rubió, Colestyramine Neon Healthcare
  • Hungary · Cholestyramine
  • Ireland · Questran
  • Italy · Questran
  • Luxembourg · Questran
  • Netherlands · Colestyramine Suikervrij Focus, Questran
  • Norway · Questran, Questran Loc
  • Portugal · Quantalan
  • Sweden · Kolestyramin Alternova, Questran

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7e8f87cb-f14b-442e-afbe-bb70e25fed58
GET /v1/drugs/7e8f87cb-f14b-442e-afbe-bb70e25fed58?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for oral suspension",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Questran 4 g",
  "name_fr": "Questran 4 g",
  "name_nl": "Questran 4 g",
  "amp_code": "SAM096153-00",
  "strengths": [
    "4.0000",
    "0.1000",
    "0.0300"
  ],
  "pack_count": 1,
  "substances": [
    "Colestyramine",
    "Propylene Glycol Alginate",
    "Aspartame"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Colestyramine",
  "authorisation_numbers": [
    "BE096153"
  ]
}
API referenceMCP serverPlans

See everything about colestyramine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console